Platelet Function Tests: How They Work and When to Use Them

·

Share

Platelet function tests measure how well your platelets stick, activate and clump together to seal a damaged blood vessel, not just how many platelets you have. Doctors order them when someone bleeds more than expected despite a normal platelet count, when an inherited platelet disorder is suspected, or occasionally to check how a person is responding to antiplatelet medicines such as aspirin or clopidogrel. The main methods are the PFA-100 screening test, light transmission aggregometry (the reference method), point-of-care assays such as VerifyNow, and flow cytometry.

A routine platelet lab test on a complete blood count tells you the number of platelets. A platelet function test answers a different question: are those platelets actually doing their job? Below, I walk through the mechanisms these tests probe, how each one works, and how the results fit into clinical decisions.

What Platelets Do and Why Function Matters

Platelets are small, anucleate cell fragments released from megakaryocytes in the bone marrow. A normal count is roughly 150,000 to 450,000 per microliter of blood, and each platelet circulates for about 7 to 10 days. Their role in platelet function in health and disease centers on primary hemostasis, the first step in stopping bleeding.

That process happens in three overlapping stages:

  • Adhesion: platelets bind to exposed collagen at an injury site, mainly through von Willebrand factor and the glycoprotein Ib-IX-V receptor.
  • Activation: platelets change shape and release granule contents such as ADP and thromboxane A2, which recruit more platelets.
  • Aggregation: the glycoprotein IIb/IIIa receptor binds fibrinogen, linking platelets together into a plug.

The platelet plug then supports the coagulation cascade, which builds a fibrin mesh as part of the wider clotting process. Later, the body breaks the clot down again through fibrinolysis, described in our article on blood clot dissolution. Because a person can have a perfectly normal count yet faulty adhesion or aggregation, function testing fills an important diagnostic gap.

Causes of Abnormal Platelet Function

Abnormal results fall into two broad groups: inherited and acquired. Acquired causes are far more common in everyday practice.

Inherited Disorders

  • Von Willebrand disease: the most common inherited bleeding disorder; low or faulty von Willebrand factor impairs platelet adhesion.
  • Glanzmann thrombasthenia: a rare defect in glycoprotein IIb/IIIa, so platelets cannot aggregate.
  • Bernard-Soulier syndrome: a rare defect in glycoprotein Ib-IX-V, typically with large platelets and a mildly low count.
  • Storage pool and secretion defects: platelets lack or cannot release their granule contents.

Acquired Causes

Medications top the list. Aspirin irreversibly blocks the enzyme cyclooxygenase-1, so its effect lasts for the life of the platelet, while other NSAIDs block it reversibly. Clopidogrel, prasugrel and ticagrelor block the P2Y12 ADP receptor. Some antidepressants (SSRIs), certain antibiotics and high-dose fish oil can also blunt function.

Chronic kidney disease (uremia), liver disease, cardiopulmonary bypass and bone marrow disorders such as myeloproliferative neoplasms and myelodysplastic syndromes can all produce platelet dysfunction. On the other side of the balance, conditions such as diabetes, obesity and smoking are associated with heightened platelet reactivity, which contributes to arterial thrombosis.

How the Main Platelet Function Tests Work

Each test isolates a different part of the platelet response, which is why no single assay answers every question.

Light Transmission Aggregometry (LTA)

LTA remains the reference method. Platelet-rich plasma is placed in a cuvette, and a series of agonists (chemicals that trigger activation) are added one at a time: ADP, collagen, epinephrine, arachidonic acid and ristocetin. As platelets clump, the plasma clears and more light passes through, producing a tracing for each agonist. The pattern across agonists points to specific defects in platelet aggregation.

PFA-100 (and PFA-200)

This analyzer draws whole blood at high shear through a tiny aperture in a membrane coated with collagen plus either epinephrine or ADP. The result is a closure time, the time taken for a platelet plug to block the opening. It is a quick screen, sensitive to severe von Willebrand disease and aspirin effect, but a normal result does not rule out milder disorders.

VerifyNow and Other Point-of-Care Assays

VerifyNow uses fibrinogen-coated beads and specific agonists to measure the response to aspirin or P2Y12 inhibitors. It is used mainly in cardiology settings rather than for diagnosing bleeding disorders.

Flow Cytometry and Viscoelastic Testing

Flow cytometry counts specific glycoproteins on the platelet surface, which helps confirm Glanzmann thrombasthenia or Bernard-Soulier syndrome. Viscoelastic tests (TEG and ROTEM), sometimes with platelet mapping, show the strength of the whole clot and are used in surgery and trauma.

Interpreting Results: Typical Patterns

Results are always read alongside the platelet count, platelet size, von Willebrand studies and the patient’s medication list. The table summarizes classic textbook patterns.

Condition LTA pattern PFA-100 closure time
Aspirin effect Reduced response to arachidonic acid; weakened collagen and epinephrine responses Prolonged with collagen/epinephrine; often normal with collagen/ADP
P2Y12 inhibitor (e.g., clopidogrel) Reduced response to ADP Variable; not reliable for monitoring
Glanzmann thrombasthenia Absent aggregation to all agonists except ristocetin Markedly prolonged
Bernard-Soulier syndrome Normal to other agonists; absent response to ristocetin Markedly prolonged
Von Willebrand disease Reduced ristocetin response (depending on type) Often prolonged

Pre-test conditions matter a great deal. Samples are collected in citrate tubes and generally tested within a few hours, and a low platelet count or low hematocrit can falsely prolong results. Where possible, doctors ask patients to stop aspirin and other NSAIDs for about 7 to 10 days beforehand, but only with medical approval, since some people take them for serious heart conditions.

Clinical Applications and Treatment Decisions

In my practice, the most common reason to order these tests is a bleeding history that doesn’t match normal routine clotting results: heavy periods since the first cycle, prolonged bleeding after dental extraction, or bleeding after surgery. Testing helps identify the defect so treatment can be matched to it.

  • Bleeding disorders: options include desmopressin (DDAVP) for some forms of von Willebrand disease and mild platelet defects, tranexamic acid for mucosal bleeding, and platelet transfusion for severe inherited disorders or major surgery.
  • Cardiovascular care: antiplatelet drugs such as aspirin and clopidogrel reduce unwanted platelet activity after heart attacks and stents. Routine function testing of every patient on these drugs is not standard, but it may be used in selected cases.
  • Surgery and trauma: viscoelastic testing can guide transfusion decisions in real time.

Research continues into the signaling pathways of platelet activation and into more standardized, easier-to-run assays, since many current tests require specialist laboratories. For a broader overview of platelet conditions, see our platelets guide.

When to See a Doctor

Ask your doctor about a bleeding evaluation if you notice:

  • Easy or unexplained bruising, especially large bruises on the trunk
  • Frequent or prolonged nosebleeds or gum bleeding
  • Heavy menstrual bleeding, particularly since your first periods
  • Excessive bleeding after dental work, surgery or childbirth
  • A family history of a bleeding disorder

Seek urgent care for bleeding that will not stop with pressure, blood in vomit or stool, or sudden severe headache. Never stop a prescribed antiplatelet medicine before a test without talking to the doctor who prescribed it.

Frequently Asked Questions

Is a platelet function test the same as a platelet count?

No. A platelet count, part of the complete blood count, measures how many platelets you have. A platelet function test measures how well they work, which can be abnormal even when the count is normal.

Why do I need to stop aspirin before testing?

Aspirin permanently disables the platelets it touches, and its effect wears off only as new platelets are made over about a week to 10 days. If you are still taking it, the test may simply show the drug’s effect and hide an underlying disorder. Only stop it if your doctor confirms it is safe.

Why is the bleeding time test no longer used?

The bleeding time involved a small standardized cut on the forearm and timing how long it bled. It was poorly reproducible, depended heavily on the operator, and did not reliably predict surgical bleeding, so laboratory assays have largely replaced it.

Can a normal PFA-100 rule out a bleeding disorder?

Not completely. The PFA-100 is good at detecting severe defects and aspirin effect but can miss milder platelet disorders and some cases of von Willebrand disease. If the history is convincing, specialist testing such as aggregometry is still warranted.

Written by
Haematology, Platelet Biology
Contact [email protected] nubama YouTube University of SantiagoMay 28, 2020Phosphoproteomic fingerprint of platelets in obesity: insights into platelet reactivity Platelet passionate moving to MK-related world. Spanish as a lifestyle. Regarding my hobbies, I love climbing and traveling, specially in a camper van.
View Full Profile →
Web Admin Avatar